vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and TE Connectivity (TEL). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $4.7B, roughly 1.2× TE Connectivity). TE Connectivity runs the higher net margin — 16.1% vs 7.9%, a 8.1% gap on every dollar of revenue. On growth, TE Connectivity posted the faster year-over-year revenue change (21.7% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
TE Connectivity plc is an American-Irish domiciled technology company that designs and manufactures electrical and electronic components. It serves several industries, including automotive, aerospace, defense, medical, and energy.
FMS vs TEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $4.7B |
| Net Profit | $434.2M | $750.0M |
| Gross Margin | 27.4% | 37.2% |
| Operating Margin | 11.7% | 20.6% |
| Net Margin | 7.9% | 16.1% |
| Revenue YoY | -0.3% | 21.7% |
| Net Profit YoY | 240.4% | 42.0% |
| EPS (diluted) | — | $2.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $4.7B | ||
| Q3 25 | — | $4.7B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.1B | ||
| Q4 24 | $5.5B | $3.8B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | — | $4.0B | ||
| Q1 24 | — | $4.0B |
| Q4 25 | $434.2M | $750.0M | ||
| Q3 25 | — | $663.0M | ||
| Q2 25 | — | $638.0M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | $127.6M | $528.0M | ||
| Q3 24 | — | $276.0M | ||
| Q2 24 | — | $573.0M | ||
| Q1 24 | — | $541.0M |
| Q4 25 | 27.4% | 37.2% | ||
| Q3 25 | — | 35.0% | ||
| Q2 25 | — | 35.3% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | 25.0% | 35.5% | ||
| Q3 24 | — | 34.0% | ||
| Q2 24 | — | 34.8% | ||
| Q1 24 | — | 34.4% |
| Q4 25 | 11.7% | 20.6% | ||
| Q3 25 | — | 19.3% | ||
| Q2 25 | — | 18.9% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | 5.1% | 18.0% | ||
| Q3 24 | — | 16.0% | ||
| Q2 24 | — | 19.0% | ||
| Q1 24 | — | 17.4% |
| Q4 25 | 7.9% | 16.1% | ||
| Q3 25 | — | 14.0% | ||
| Q2 25 | — | 14.1% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | 2.3% | 13.8% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 14.4% | ||
| Q1 24 | — | 13.6% |
| Q4 25 | — | $2.53 | ||
| Q3 25 | — | $2.23 | ||
| Q2 25 | — | $2.14 | ||
| Q1 25 | — | $0.04 | ||
| Q4 24 | — | $1.75 | ||
| Q3 24 | — | $0.96 | ||
| Q2 24 | — | $1.86 | ||
| Q1 24 | — | $1.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $1.3B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.4B | $13.0B |
| Total Assets | $33.5B | $25.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $672.0M | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | $15.4B | $13.0B | ||
| Q3 25 | — | $12.6B | ||
| Q2 25 | — | $12.4B | ||
| Q1 25 | — | $12.1B | ||
| Q4 24 | $17.0B | $12.4B | ||
| Q3 24 | — | $12.4B | ||
| Q2 24 | — | $12.6B | ||
| Q1 24 | — | $12.4B |
| Q4 25 | $33.5B | $25.6B | ||
| Q3 25 | — | $25.1B | ||
| Q2 25 | — | $24.9B | ||
| Q1 25 | — | $23.7B | ||
| Q4 24 | $36.3B | $22.4B | ||
| Q3 24 | — | $22.9B | ||
| Q2 24 | — | $22.9B | ||
| Q1 24 | — | $22.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $865.0M |
| Free Cash FlowOCF − Capex | — | $607.0M |
| FCF MarginFCF / Revenue | — | 13.0% |
| Capex IntensityCapex / Revenue | — | 5.5% |
| Cash ConversionOCF / Net Profit | 6.67× | 1.15× |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.1B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $865.0M | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $653.0M | ||
| Q4 24 | $2.6B | $878.0M | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | $710.0M |
| Q4 25 | — | $607.0M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $957.0M | ||
| Q1 25 | — | $423.0M | ||
| Q4 24 | — | $673.0M | ||
| Q3 24 | — | $829.0M | ||
| Q2 24 | — | $857.0M | ||
| Q1 24 | — | $543.0M |
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 21.1% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | — | 20.4% | ||
| Q2 24 | — | 21.5% | ||
| Q1 24 | — | 13.7% |
| Q4 25 | — | 5.5% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 5.1% | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | — | 5.2% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | 4.2% |
| Q4 25 | 6.67× | 1.15× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | 1.86× | ||
| Q1 25 | — | 50.23× | ||
| Q4 24 | 20.20× | 1.66× | ||
| Q3 24 | — | 3.78× | ||
| Q2 24 | — | 1.76× | ||
| Q1 24 | — | 1.31× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMS
Segment breakdown not available.
TEL
| Automotive Industry End Market | $1.9B | 40% |
| Digital Data Networks | $707.0M | 15% |
| Automation And Connected Living Industry End Market | $549.0M | 12% |
| Energy Industry End Market | $406.0M | 9% |
| Aerospace Defense And Marine Industry End Market | $381.0M | 8% |
| Commercial Transportation Industry End Market | $370.0M | 8% |
| Sensors Industry End Market | $212.0M | 5% |
| Medical Industry End Market | $159.0M | 3% |
